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Recent epidemiological studies have demonstrated that coffee drinking is associated with reduced
mortality of cardiovascular disease. However, its precise mechanisms remain to be clariﬁed. In this study,
we examined whether single ingestion of caffeine contained in a cup of coffee improves microvascular
function in healthy subjects.
A double-blind, placebo-controlled, crossover study was performed in 27 healthy volunteers. A cup of
either caffeinated or decaffeinated coffee was drunk by the subjects, and reactive hyperemia of ﬁnger
blood ﬂow was assessed by laser Doppler ﬂowmetry. In an interval of more than 2 days, the same
experimental protocol was repeated with another coffee in a crossover manner. Caffeinated coffee intake
slightly but signiﬁcantly elevated blood pressure and decreased ﬁnger blood ﬂow as compared with
decaffeinated coffee intake. There was no signiﬁcant difference in heart rate between caffeinated and
decaffeinated coffee intake. Importantly, caffeinated coffee intake signiﬁcantly enhanced post-occlusive
reactive hyperemia of ﬁnger blood ﬂow, an index of microvascular endothelial function, compared with
decaffeinated coffee intake.
These results provide the ﬁrst evidence that caffeine contained in a cup of coffee enhances micro-
vascular function in healthy individuals.
© 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Coffee is the most widely consumed beverage in the world (1).
Coffee contains a variety of pharmacologically active ingredients,
and it has long been argued whether coffee drinking is beneﬁcial or
harmful for cardiovascular disease (2e4). Recently, a large cohort
study, in which more than 400,000 participants were prospectively
followed up for 13 years, has demonstrated that coffeecology, Graduate School of
ishihara-cho, Okinawa 903-
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Production and hosting by Elsevieconsumption is associatedwith reducedmortality of cardiovascular
disease (5). Moreover, a meta-analysis of 23 prospective studies has
provided quantitative evidence that coffee intake is inversely
related to cardiovascular disease mortality (6). These ﬁndings
suggest the beneﬁcial cardiovascular actions of coffee. However, its
precise mechanisms remain to be elucidated.
The vascular endothelium synthesizes and releases several
vasodilating substances, such as prostacyclin, nitric oxide, and
endothelium-derived hyperpolarizing factors (EDHF). Evaluation of
endothelial function has been shown to provide important prog-
nostic information in patients with cardiovascular disease, as evi-
denced by the facts that the severity of endothelial dysfunction can
predict future cardiovascular events (7, 8) and that improvement of
endothelial function by pharmacological interventions reduces the
risk of cardiovascular disease. Acute effects of caffeine, a majorr B.V. All rights reserved.
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lial function of large conduit arteries have been examined in several
previous studies by using ultrasound-based measurement of
brachial artery diameter during post-occlusive reactive hyperemia.
However, the results of those studies are quite inconsistent (9e13).
It is generally accepted that ﬂow-dependent dilation of conduit
arteries is mediated primarily by nitric oxide (14), while in the
microcirculation EDHF rather than nitric oxide have been suggested
to play a major role in the reactive hyperemic response (15).
Microvessels, but not large arteries, regulate tissue blood blow and
systemic blood pressure, and thereby play a key role in the circu-
latory system. However, no study has ever addressed the effect of
caffeine on microvascular function.
Based on the above background, we examined in this study the
effect of single ingestion of a cup of caffeinated and decaffeinated
coffee on ﬁnger microvascular function in healthy subjects by laser
Doppler ﬂowmetry.
2. Methods
2.1. Subjects
We recruited twenty-seven healthy subjects (13 men and 14
women; 22e30 years old [mean age, 23.7 ± 2.2]; mean body
weight, 58.4 ± 15.1 kg; mean height, 162.9 ± 9.6 cm) in our uni-
versity, and the subjects who wanted to take part in the study
voluntarily were investigated. Subjects taking any medication or
smokers were excluded from the study, and the experiments were
performedwhen the subjects werewell conditioned. All volunteers
were asked to abstain from caffeine-contained beverages at least
12 h before the study. All subjects gave written informed consent,
and invasive experiments including blood sampling were approved
by the Clinical Trial Ethics Committee of the University of the
Ryukyus, according to the declaration of Helsinki and the ethical
standard.
2.2. Study design
A double-blind, placebo-controlled, crossover study was per-
formed. All participants were examined on two separate days in a
quiet temperature-controlled room. Instant coffee of 2 g with or
without caffeine (Taster's Choice™, Nestle, Vevey, Switzerland)
was prepared with 150 ml hot water. Neither sugar nor milk was
added. A cup of the caffeinated or decaffeinated coffee was
ingested in each subject. Hemodynamic variables and reactive
hyperemic response were measured before and every 15 min
after coffee intake. In a pilot study, we were not able to continue
this experiment more than 75 min because some subjects com-
plained of strong pain due to repeated cuff-compression or a
ﬁxed position of the test arm. Thus, we set the experiment time
for 75 min. In an interval of more than 2 days, the same exper-
imental protocol was repeated with another coffee in a crossover
manner. Blood pressures were measured at the brachial artery
using a sphygmomanometer (BP-103i, Nihon Colin, Komaki,
Japan). A manchette was placed around the right upper arm, and
a mean value of three measurements was used for the statistical
analyses. Heart rate was obtained from the sphygmomanometer.
The subjects were in a sitting position throughout the
experiments.
2.3. Assessment of microvascular function
Finger blood ﬂow was measured by a laser Doppler ﬂowmeter
(ALF21, Advance, Tokyo, Japan). A ﬂow-probe (type C) was placed at
the tip of the left index ﬁnger or thumb. Blood ﬂow was calculatedby measuring Doppler shifts derived frommoving erythrocytes per
photon and the mean photon frequency. As the number of Doppler
shifts is proportional to the erythrocyte volume and velocity, blood
ﬂow is the product of linearized volume and velocity (16). Post-
occlusive reactive hyperemia of ﬁnger blood ﬂow was assessed as
an index of microvascular endothelial function. A cuff was placed
on the left upper arm, and reactive hyperemia of ﬁnger blood ﬂow
was induced by inﬂating a cuff for 1 min in order to interrupt
arterial blood ﬂow and then deﬂating it. Peak hyperemic ﬂow was
deﬁned as the highest blood ﬂow immediately after cuff deﬂation.
Reactive hyperemia was calculated according to the following
equation:
Reactive hyperemia (%) ¼ [(peak hyperemic ﬂow  resting
ﬂow)/resting ﬂow]  100
2.4. Measurement of caffeine and catecholamine levels
Venous blood samples were collected before and 30 min after
coffee ingestion in ﬁve volunteers. The plasma caffeine levels and
caffeine contents in decaffeinated and caffeinated coffee were
analyzed by high performance liquid chromatography (HPLC; LC-
10AD, Shimadzu, Kyoto, Japan) (17). Plasma catecholamine levels
were measured by SRL Inc. (Tokyo, Japan) using the HPLC method.
2.5. Statistical analysis
Statistical analyses were performed by a two-way ANOVA fol-
lowed by a Bonferoni/Dunn post hoc test. When paired or unpaired
data were compared, a paired or unpaired Student's t-test,
respectively, was applied. The computer software StatView-J 5.0
(SAS Institute Japan Ltd, Tokyo, Japan) was used for the statistical
analyses. A value of P < 0.05 was considered to be statistically
signiﬁcant. Results are expressed as mean ± SD.
Reproducibility of laser Doppler ﬂowmetry was expressed as
within-subject coefﬁcients of variability. In our laboratory, the
intra-day variability for ﬁnger blood ﬂowwas 6.3% (range: 0e27.1%)
and that for reactive hyperemia assessed by laser Doppler ﬂow-
metry was 21.6% (0e54.2%), and the day-to-day variability for
ﬁnger blood ﬂow was 26.2% (0e76.1%) and that for reactive hy-
peremiawas 33.7% (0e102%). According to the previous studies, the
coefﬁcient of variance < 35% can be deemed acceptable (18).
3. Results
3.1. Caffeine content in decaffeinated and caffeinated coffee and
plasma caffeine levels before and after coffee intake
Caffeine content in decaffeinated vs. caffeinated coffee was
markedly different (1.37 ± 0.09 vs. 54.5 ± 3.4 mg, respectively)
(Fig. 1A). Before coffee intake, plasma caffeine levels were identical
between subjects with decaffeinated and caffeinated coffee intake.
However, 30 min after coffee intake, plasma caffeine levels were
markedly increased in the subjects with caffeinated coffee intake
(from 0.75 ± 0.85 to 1.57 ± 1.30 mg/ml, P < 0.05), but not in those
with decaffeinated coffee intake (from 0.76 ± 0.57 to 0.77 ± 0.60 mg/
ml) (Fig. 1B).
3.2. Effects of caffeinated coffee intake on blood pressure and ﬁnger
blood ﬂow
Before coffee intake, there were no signiﬁcant differences in
baseline hemodynamic variables (i.e., systolic, diastolic, and mean
blood pressures, ﬁnger blood ﬂow, vascular resistance, or heart
rate) in the subjects with decaffeinated and caffeinated coffee
intake (Table 1). However, caffeinated coffee intake, but not
Fig. 1. Caffeine contents in a cup of decaffeinated and caffeinated coffee (A) and plasma caffeine levels before and 30 min after single intake of caffeinated and decaffeinated coffee
(B). Data are expressed as mean ± SD. *P < 0.05 between before and after coffee intake by a paired t-test.
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of systolic, diastolic andmean blood pressures bymaximally 2.7, 3.2
and 2.8 mmHg, respectively (each P < 0.01, Fig. 2). Furthermore,
caffeinated coffee intake signiﬁcantly reduced ﬁnger blood ﬂow (as
assessed by laser-Doppler ﬂowmetry, P < 0.01, Fig. 3A) and signif-
icantly increased vascular resistance of the ﬁnger vascular bed
when compared with decaffeinated coffee intake (P < 0.01, Fig. 3B).
On the other hand, there was no signiﬁcant difference in heart rate
in the subjects with decaffeinated and caffeinate coffee intake
(Fig. 3C).3.3. Effects of caffeinated coffee intake on reactive hyperemia of
ﬁnger blood ﬂow
Before coffee intake, post-occlusive reactive hyperemia of ﬁnger
blood ﬂow, an index of microvascular endothelial function, were
comparable between the subjects with decaffeinated and caffein-
ated coffee (8.7 ± 4.3 and 10.0 ± 3.4 ml/min/100 g, respectively).
However, caffeinated coffee intake signiﬁcantly enhanced post-
occlusive reactive hyperemia of ﬁnger blood as compared with
decaffeinated coffee intake (P < 0.01, Fig. 4).3.4. Plasma catecholamine levels
Plasma norepinephrine levels did not signiﬁcantly differ be-
tween the subjects with decaffeinated and caffeinated coffee intake
at baseline (336 ± 132 vs. 317 ± 165 pg/ml) and at 30 min after the
intake (271 ± 95 vs. 272 ± 125 pg/ml). Plasma epinephrine levels
also did not signiﬁcantly alter between the subjects with decaf-
feinated and caffeinated coffee intake at baseline (35.8 ± 12.5 vs.
33.3 ± 18.5 pg/ml) and at 30 min after the intake (32.0 ± 11.2 vs.
25.8 ± 13.5 pg/ml). The respective plasma catecholamine levels did
not signiﬁcantly change before and after coffee intake.Table 1
Baseline characteristics in subjects with decaffeinated and caffeinated coffee intake.
Variables Decaffeinated Caffeinated P value
Systolic BP (mmHg) 104.9 ± 12.4 106.2 ± 11.2 0.346
Diastolic BP (mmHg) 58.0 ± 8.3 59.1 ± 6.6 0.297
Mean BP (mmHg) 73.6 ± 8.8 74.8 ± 7.6 0.264
Finger blood ﬂow (ml/min/100 g) 23.6 ± 7.7 23.3 ± 7.9 0.916
Vascular resistance (unit) 3.43 ± 1.15 3.67 ± 1.63 0.543
Reactive hyperemia (%) 40.8 ± 25.4 50.3 ± 27.1 0.125
Heart rate (bpm) 74.6 ± 9.4 74.3 ± 8.6 0.815
BP ¼ blood pressure, Vascular resistance ¼ vascular resistance of the ﬁnger vascular
bed (ﬁnger blood ﬂow/mean BP), Reactive hyperemia (%) ¼ 100  (post-occlusive
increase in ﬁnger blood ﬂow)/(baseline ﬁnger blood ﬂow).4. Discussion
To the best of our knowledge, this is the ﬁrst study examining
the acute effect of caffeine on endothelial function in the human
ﬁnger cutaneous microcirculation. The present study demonstrates
that an intake of caffeine contained in a cup of coffee may cause a
favorable effect onmicrovascular endothelial function assessed by a
noninvasive laser Doppler ﬂowmetry method in Japanese young
healthy subjects.
4.1. Pressor effect of caffeine
In the present study, the plasma caffeine concentration after
caffeinated coffee intake attained 1.6 mg/ml. This concentration of
caffeine has been shown to act as an antagonist of adenosine A1/A2A
receptors (19, 20). As adenosine causes vasodilation in most
vascular beds (21), caffeine would induce an increase in vascular
resistance. Thus, slight but signiﬁcant rises in blood pressure
observed after caffeinated coffee intake in the present studymay, in
part, be caused by an increase in basal vascular tone derived from
the adenosine antagonism of caffeine, as found by an early study
(22). In addition, a direct stimulatory effect of caffeine on myocar-
dial contractility (23) might be involved in a signiﬁcant increase in
blood pressure seen after caffeinated coffee intake.
4.2. Effect of caffeine on microvascular function
The present ﬁnding that caffeine ingestion, even at a small dose
(54.5 mg ¼ less than 1 mg/kg), improves microvascular endothelial
function is consistent with a previous study (24) using venous oc-
clusion plethysmography demonstrating that the acute adminis-
tration of caffeine at an extremely large dose (300 mg) augments
vasodilator responses of forearm vessels to intra-arterial infusion of
the endothelium-dependent agonist acetylcholine.
In contrast to our study, however, two previous reports using
ultrasound-based measurement of brachial artery diameter during
post-occlusive reactive hyperemia demonstrated that caffeinated
coffee ingestion impaired endothelial function in healthy volun-
teers (9, 12). In addition, two other studies showed that acutely
administered caffeine had no effect on endothelial function
assessed by the brachial artery vasoreactivity measurement (10,
11). Although the reason for conﬂicting with our data cannot be
fully explained at present, it seems plausible that the difference in
the type of vessels used for assessing vascular function was mainly
involved. Laser Doppler ﬂowmetry employed in the present study
measures microvascular function in cutaneous arterioles and cap-
illaries, whereas the ultrasound-based measurement of brachial
artery diameter reﬂects ‘macrovascular’ function in large conduit
Fig. 2. Effects of caffeinated and decaffeinated coffee intake on systolic (A), diastolic
(B) and mean (C) blood pressures (BP). Data are expressed as mean ± SD. **P < 0.01
between caffeine () and caffeine (þ) by ANOVA.
Fig. 3. Effects of caffeinated and decaffeinated coffee intake on ﬁnger blood ﬂow (A),
vascular resistance of the ﬁnger vascular bed (B), and heart rate (C). Data are expressed
as mean ± SD. **P < 0.01 between caffeine () and caffeine (þ) by ANOVA.
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artery responses to reactive hyperemia do not correlate with
microvascular function as measured by agonist infusion studies or
laser Doppler ﬂowmetry (25, 26). It is generally considered that
ﬂow-dependent dilation of conduit arteries is mediated primarily
by nitric oxide (14). By contrast, contribution of nitric oxide to post-occlusive reactive hyperemia in microvessels appears minimal (27,
28). Instead, EDHF may have a major role in the reactive hyperemic
response in the microcirculation (15). Although the nature and
mechanisms of EDHF remain uncertain, EDHF response has been
proposed to be divided into two broad categories as follows: the
ﬁrst (classical) EDHF pathway is associated with endothelial cell
hyperpolarization due to the opening of endothelial calcium-
Fig. 4. Effect of caffeinated and decaffeinated coffee intake on post-occlusive reactive
hyperemia of ﬁnger blood ﬂow. Reactive hyperemia was calculated according to the
following equation: reactive hyperemia (%) ¼ [(peak hyperemic ﬂow  resting ﬂow)/
resting ﬂow]  100. Data are expressed as mean ± SD. **P < 0.01 between caffeine ()
and caffeine (þ) by ANOVA.
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require endothelial hyperpolarization but involves the endothelial
release of factors that hyperpolarize vascular smooth muscle cells
by opening various myocyte Kþ-channels such as calcium-activated
Kþ-channels (29). Experimental studies with animal and human
vessels have demonstrated that the activation of vascular smooth
muscle Ca2þ-activated Kþ channels probably contributes to the
EDHF component of reactive hyperemia in microvessels (30, 31).
Thus, microvascular endothelial function assessed by laser Doppler
ﬂowmetry may reﬂect the bioavailability of endothelium-
dependent hyperpolarization via the activation of Ca2þ-activated
Kþ channels in the endothelium and/or vascular smooth muscles.4.3. Possible mechanisms involved in the beneﬁcial effect of caffeine
on microvascular function
In addition to the action on adenosine receptors, caffeine has
been known to have a variety of pharmacological properties,
including inhibition of phosphodiesterase (32), and calcium release
from intracellular calcium stores via ryanodine-sensitive calcium
channels (33). Interestingly, several electrophysiological experi-
ments have displayed that caffeine at concentrations ranging from
106 to 103 M evokes calcium-dependent hyperpolarization in
endothelial cells and vascular smooth muscle cells as a result of
increased outward Kþ current (34e36). These data suggest that
caffeine-induced release of calcium from intracellular calcium
stores elicits the activation of calcium-activated Kþ-channels in
these cells. Considering that EDHF, unlike nitric oxide, has a major
role in microvascular reactive hyperemia, it is possible that caffeine
has the potential to augment the reactive hyperemic response of
microvessels through amplifying hyperpolarization caused by
EDHF. This may explain a favorable effect of caffeine on microvas-
cular endothelial function in the present study, because the plasma
concentration of caffeine was estimated to be nearly 105 M
(Fig. 1B). It is intriguing that previous experiments in rats have
shown that treatment with blockers of calcium-activated Kþ-
channels dose not affect baseline blood pressure or vascular
conductance but attenuates vasodilator responses of resistance
vessels produced by endothelium-dependent vasodilators such as
acetylcholine (37, 38). These ﬁndings indicate that calcium-
activated Kþ-channels contribute little to the regulation of basal
blood pressure but participate in responses to endothelialstimulation, and may be related to the present results that caffeine
intake produced enhancement of microvascular endothelial func-
tion in spite of the occurrence of a slight increase in baseline blood
pressure.
Several clinical studies (13, 39e41) have shown that caffeine
exerts acute beneﬁcial metabolic effects such as increased con-
centrations of adiponectin, a marker of anti-inﬂammatory and
insulin-sensitizing effects (42). In addition, a cross-sectional study
has reported that coffee consumption is inversely associated with a
plasma marker of inﬂammation (C-reactive protein) and that of
endothelial dysfunction (E-selectin) (43). Thus, these preferable
properties of caffeine, besides the effect on endothelial function,
may partly account for the beneﬁcial cardiovascular effect of long-
term coffee consumption.
4.4. Study limitations
Our study has some potential limitations to be considered. First,
the number of subjects examined in this study may have been so
small as to provide conclusive proof, although statistically signiﬁ-
cant effects were found. Second, the long-term effects of caffeine
ingestion on endothelial function remain unknown. Third, we did
not ask female subjects about the menstrual cycle, and it is thus
unknown to what extent its phases affected the ﬁnger blood ﬂow
response. Finally, assessment of microvascular function was per-
formed solely in Japanese healthy young volunteers. We have not
yet elucidated whether or not caffeinated coffee intake ameliorates
microvascular endothelial function not only in healthy subjects but
also in patients with cardiovascular disease. These issues remain to
be examined in future studies.
5. Conclusion
Our double-blind, placebo-controlled, crossover study has
demonstrated, for the ﬁrst time, that caffeine at the amount con-
tained in a cup of coffee may cause improvement of microvascular
endothelial function in healthy subjects.
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